ALS Therapy Development Institute - PDFSEARCH.IO - Document Search Engine

ALS Therapy Development Institute
Results: 115

#	Item
11	Microsoft Word - Corey Reich Giants+Angels[removed]doc Add to Reading List Source URL: www.als.net Language: English - Date: 2010-01-12 14:09:51 Health ALS Association Amyotrophic lateral sclerosis Muscular Dystrophy Association Neuroscience ALS Society of Canada James Heywood ALS Therapy Development Institute Rare diseases Motor neurone disease
12	Young Faces of ALS Campaign Launches 4th Annual National Corntoss Challenge Tournament April 14, 2014 – CAMBRIDGE, MA – The ALS Therapy Development Institute (ALS TDI), through its Young Faces of ALS (YFALS) campaign Add to Reading List Source URL: www.als.net Language: English - Date: 2014-04-15 12:16:55 Amyotrophic lateral sclerosis Motor neurone disease ALS Society of Canada James Heywood Rare diseases Health ALS Therapy Development Institute
13	The ALS Therapy Development Institute Partners with Regenesance BV to Investigate Potential Treatments for Lou Gehrig’s Disease Complement Pathway Modulation at Center of Collaboration May 7, [removed]CAMBRIDGE & AMSTERD Add to Reading List Source URL: www.als.net Language: English - Date: 2012-11-16 16:34:17 Health Amyotrophic lateral sclerosis Neuroscience Sean F. Scott James Heywood ALS Therapy Development Institute Rare diseases Motor neurone disease
14	ALS Therapy Development Institute and Anida Pharma Partner to Investigate Potential Treatments for ALS Add to Reading List Source URL: www.als.net Language: English - Date: 2013-09-10 08:43:00 Health Amyotrophic lateral sclerosis SOD1 Neuroscience Sean F. Scott James Heywood ALS Therapy Development Institute Motor neurone disease Rare diseases
15	Avon Products, Inc. Launches National Fundraising Program for ALS TDI to Advance Treatments for ALS Necklace Named in Honor of Avon Executive Recently Diagnosed with Lou Gehrig’s Disease CAMBRIDGE, MASS. – November 1 Add to Reading List Source URL: www.als.net Language: English - Date: 2012-11-16 16:21:31 Motor neurone disease Avon Products Health Amyotrophic lateral sclerosis Cally Andrea Jung Marketing James Heywood ALS Therapy Development Institute Business Rare diseases
16	ALS Therapy Development Institute and to-BBB Collaborate on Potential Treatments for Motor Neuron Disease CNS-targeted Liposomal Drug Delivery System Enhances Institute’s Formulation Abilities January 8, 2013 – CAMBR Add to Reading List Source URL: www.als.net Language: English - Date: 2013-01-08 09:30:54 Biology Neurology Motor neurone disease Medicine Blood–brain barrier Amyotrophic lateral sclerosis Creatine Prize4Life James Heywood Rare diseases Health ALS Therapy Development Institute
17	Media Contacts Sean A. Scott, President ALS Therapy Development Institute[removed]removed] Charles Versaggi, Ph.D. Add to Reading List Source URL: www.als.net Language: English - Date: 2008-02-05 13:21:33 Amyotrophic lateral sclerosis ALS Therapy Development Institute Medicine Chemistry SOD1 Riluzole Augie Nieto Minocycline Creatine Health Rare diseases Motor neurone disease
18	The Dangers of Unproven Therapies_FactSheet-1page.qxd Add to Reading List Source URL: www.als.ca Language: English - Date: 2012-12-31 17:17:15 Stem cells Motor neurone disease Amyotrophic lateral sclerosis ALS Therapy Development Institute SOD1 Stem cell treatments Cell therapy Biology Rare diseases Health
19	Media Contacts: Robert A. Goldstein, ALS TDI, [removed], [removed] FOR IMMEDIATE RELEASE Pharma and Biotech CEOs, Academic Scientists, Funders and Patients to Meet on ALS Drug Development this Fall 7th Annual Add to Reading List Source URL: www.als.net Language: English - Date: 2011-06-07 11:25:07 Rare diseases Amyotrophic lateral sclerosis National Institutes of Health Biogen Idec James Heywood Health ALS Therapy Development Institute Medicine
20	PDF Document Add to Reading List Source URL: www.als.net Language: English - Date: 2012-11-16 16:41:18 ALS Therapy Development Institute Prize4Life Rare diseases Amyotrophic lateral sclerosis SOD1 Drug discovery Medicine James Heywood Pharmaceutical sciences Health Pharmacology

UPDATE